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PermeabilityThis paper describes the formation of giant proteoliposomes containing P-glycoprotein (P-gp) from a solution of
small proteoliposomes that had been deposited and partially dried on a ﬁlm of agarose. This preparationmethod
generated a signiﬁcant fraction of giant proteoliposomes thatwere free of internalized vesicles,making it possible
to determine the accessible liposome volume. Measuring the intensity of the ﬂuorescent substrate rhodamine
123 (Rho123) inside and outside these giant proteoliposomes determined the concentration of transported sub-
strates of P-gp. Fitting a kinetic model to the ﬂuorescence data revealed the rate of passive diffusion as well as
active transport by reconstituted P-gp in the membrane. This approach determined estimates for the membrane
permeability coefﬁcient (Ps) of passive diffusion and rate constants of active transport (kT) by P-gp as a result of
different experimental conditions. The Ps value for Rho123 was larger in membranes containing P-gp under all
assay conditions than inmembraneswithout P-gp indicating increased leakiness in the presence of reconstituted
transmembrane proteins. For P-gp liposomes, the kT value was signiﬁcantly higher in the presence of ATP than in
its absence or in the presence of ATP and the competitive inhibitor verapamil. This difference in kT values veriﬁed
that P-gp was functionally active after reconstitution and quantiﬁed the rate of active transport. Lastly, patch
clamp experiments on giant proteoliposomes showed ion channel activity consistentwith a chloride ion channel
protein that co-puriﬁed with P-gp. Together, these results demonstrate several advantages of using giant rather
than small proteoliposomes to characterize transport properties of transport proteins and ion channels.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Giant liposomes are useful models to study diffusion or transport of
solutes across biological membranes since their interiors are isolated
from the surrounding ﬂuid by a self-enclosing membrane and can be
observed individually by optical microscopy [1–5]. To study protein-
mediated transport, functional transmembrane proteins must be incor-
porated into the membrane of giant liposomes that consist of a single
lipid bilayer (giant unilamellar vesicle, GUV). Few methods exist for
the production of such giant proteoliposomes with active ion channelsorescence intensity inside lipo-
e at time, t; kT, rate constant of
benzoic acid; P-gp, P-glycopro-
Rho123, rhodamine 123; SUV,
ngineering and Department of
l Avenue, Ann Arbor, MI 48109,or transporter proteins due to the sensitive and fragile nature of many
transmembrane proteins and GUVs [6–10]. In addition, existing
methods can lead to giant proteoliposomes that enclose many smaller
liposomes making it difﬁcult to determine the accessible volume inside
these liposomes.
Many of the current methods for forming giant proteoliposomes are
variations of the classic protocols of gentle hydration or electroformation,
but with a carefully executed, gentle dehydration step to prevent dena-
turation of the proteins [7,11–19]. To this end, most methods involve
reconstituting transmembrane proteins into small unilamellar vesicles
(SUVs), and then partially drying the SUVs into a ﬁlm under controlled
conditions before rehydrating the ﬁlm in an aqueous solution [15–18].
Chemicals such as carbohydrates or ethylene glycol may be added to
prevent complete dehydration [16–19]. Additionally, formation of giant
proteoliposomes using water-in-oil droplet transfer technique [20] or
by fusion of small proteoliposomes with pre-formed GUVs [15,21,22]
has also been reported. These methods, however, can have limitations
with regard to their ﬁnal lipid or protein composition [6,7,23]. Alterna-
tively, Dezi et al. reported a method to directly incorporate proteins
from detergents into liposomes [8].
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assist formation of protein-free GUVs in solutions of physiologic ionic
strength [24]. Since the ﬁlm of agarose provided partial hydration, we
hence hypothesized that such a ﬁlm of agarose might be useful for
reconstituting membrane proteins into giant proteoliposomes. The
Malmstadt group has recently reported an elegant approach to form
giant proteoliposomes that used direct dilution of detergent-solubilized
membrane proteins in combinationwith lipid hydration from an agarose
ﬁlm [25,26]. Here, we explored whether hydrogel ﬁlms might also be
useful for the formation of giant proteoliposomes from small proteolipo-
somes since small proteoliposomes are one of the most commonly used
membrane protein preparations. To this end, we reconstituted the
human multidrug resistance-linked ABCB1 transporter, commonly
known as P-glycoprotein (P-gp) [27], in GUVs using this method. P-gp,
a member of ATP-binding cassette (ABC) family, contains two ATP bind-
ing domains and 12 transmembrane α-helices [28–32]. By hydrolyzing
ATP, P-gp actively efﬂuxes a broad range of hydrophobic or amphipathic
molecules, leading to the development ofmulti-drug resistance (MDR) of
cancer cells [28–32]. The ability to assay P-gp activity for biophysical
studies as well as drug screening and development is of interest due to
the role of P-gp in the blood–brain barrier and in cancer cells [29–32].
Attempts to study P-gp activity thus far have been restricted primarily
to cell-based assays. Consequently, measured transport rates, with or
without potential modulators, can be complicated by the presence of
other transporter proteins and cellular constituents [31–33]. Liposome-
based studies using puriﬁed P-gp have been conducted using primarily
small proteoliposomes due, in part, to the difﬁculty of incorporating
P-gp into giant proteoliposomes [6,34–36]. Sasaki et al. [37] recently
described a transport assay using commercially available giant proteoli-
posomes (diameter b 3 μm) containing reconstituted P-gp. The ﬂuores-
cent substrate was restricted to sub-μM concentrations because the
signal inside the liposomes would otherwise be affected by accumula-
tion of ﬂuorescent substrate on or in the membrane.
In thework presented here, we reconstituted puriﬁed P-gp and then
assessed its functionality by (i) measuring the rate of ATP hydrolysis,
and (ii) determining the passive and active transport rates by a ﬂuores-
cence ﬂux assay, and performed patch clamp experiments of a putative
chloride channel that co-puriﬁed with P-gp [38]. We introduce a
straightforward model for the transport of the ﬂuorescent substrate in
and out of liposomes. This model makes it possible to distinguish be-
tween passive diffusion and active transport of a ﬂuorescent molecule.
This distinction is important because reconstitution of transmembrane
proteins typically increases passive diffusion through liposome mem-
branes [39] while the transport rate of efﬂux pumps and other trans-
porter proteins is typically relatively slow [27]. A model that cannot
distinguish between active and passive transport may therefore be
dominated by the passive term and hence be inadequate for quantita-
tive analysis.
2. Materials and methods
Chemicals were purchased from Sigma-Aldrich (St. Louis, MO),
except when noted otherwise.
2.1. Isolation of crude membranes from P-gp-expressing high ﬁve insect cells
We prepared crude membranes from High Five insect cells infected
with recombinant baculovirus carrying the 6 × His-tagged human
MDR1 cDNA as described previously [40]. We incubated cells on ice
for 45 min in a lysis buffer containing 50 mM trizma hydrochloride
(Tris–HCl), pH 7.5, 50 mMmannitol, 2 mM ethylene glycol tetraacetic
acid (EGTA), 2 mM dithiothreitol (DTT), 1 mM 4-(2-aminoethyl)
benzenesulfonyl ﬂuoride (AEBSF), and 1% (w/v) aprotinin (Roche Diag-
nostics, Indianapolis, IN) and subsequently disrupted the cells using a
Dounce homogenizer (30 strokes with pestle A). We removed
undisrupted cells and nuclear debris by centrifugation at 500 ×g for10 min. We diluted the supernatant 2-fold in resuspension buffer con-
taining 50 mM Tris–HCl (pH 7.5), 300 mM mannitol, 1 mM EGTA,
1 mM DTT, 1 mM AEBSF, and 1% (w/v) aprotinin. We collected the
membranes by centrifugation for 60min at 100,000 ×g and resuspended
the pellet in resuspension buffer containing 10% (v/v) glycerol.We stored
the membranes in small aliquots at−70 °C. The Amido Black protein
method described by Schaffner andWeissmann [41] revealed the protein
content of each preparation with bovine serum albumin (BSA) as a
standard.
2.2. Solubilization of P-gp
We solubilized membranes prepared from High Five insect cells
using octyl β-D-glucopyranoside as described [42–44] with modiﬁ-
cations. We resuspended crude membranes at a concentration of
2.0 mg/mL in a buffer containing: 20 mM Tris–HCl (pH 8.0), 20%
(v/v) glycerol, 150 mM NaCl, 2 mM β-mercaptoethanol, 2.0% (w/v)
octyl glucoside, 1.5 mM MgCl2, 1 mM AEBSF, 2 μg/mL pepstatin,
2 μg/mL leupeptin, 1% (w/v) aprotinin and a 0.4% (w/v) lipid mixture
consisting of Escherichia coli bulk phospholipid, phosphatidylcholine,
phosphatidylserine, and cholesterol (all from Avanti Polar Lipids,
Alabaster, AL) at 60:17.5:10:12.5 (w/w), respectively [42,45]. After
20min of incubation on ice, we removed insolublematerial by centrifu-
gation at 100,000 ×g for 1 h. The supernatant, which we call detergent
extract, contained the solubilized P-gp.
2.3. Puriﬁcation of P-gp by metal afﬁnity chromatography
We puriﬁed P-gp as previously described [42–44] with modiﬁca-
tions. Brieﬂy, we incubated the detergent extract (10 mg of protein) in
the presence of 2 mM imidazole (ﬁnal concentration) for 30 min at
4 °C on a rotary shaker with 0.5 mL of 50% (w/v) Talon metal afﬁnity
resin in non-buffered 20% ethanol (Clontech, Mountain View, CA). The
resin was prewashed once with buffer A composed of 20 mM Tris–HCl
(pH 8.0), 100 mM NaCl, 20% (v/v) glycerol, 2.5 mM β-mercaptoethanol,
1.25% (w/v) octyl glucoside, 1mMMgCl2, 1mMAEBSF, 2 μg/mLpepstatin,
2 μg/mL leupeptin, 1% (w/v) aprotinin and a 0.1% (w/v) lipid mixture
(same composition as the solubilization reaction). We pelleted the
metal afﬁnity beads by centrifugation for 5 min at 500 ×g and washed
twice by resuspending and incubating in 10 mL of buffer A at 4 °C for
10 min on a rotary shaker. We resuspended the beads in 1 mL of buffer
A and transferred them to a 4 mL disposable column (Bio-Rad, Hercules,
CA). After being washed twice in 5 mL of buffer A containing 500 mM
KCl, we eluted the proteins stepwise in 2 mL each of buffer B (same as
buffer A except with 20 mM Tris–HCl at pH 6.8 instead of at pH 8.0) con-
taining 10, 100, and 200 mM imidazole. We concentrated the fractions
eluted from the column using Centriprep-50 concentrators (Amicon,
Beverly, MA) and stored in aliquots at−70 °C. We analyzed the protein
content of the puriﬁed sample by the Amido Black protein method and
performed sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) and immunoblot analysis (Fig. S3) as previously described
[41,42]. We estimate the purity of this P-gp preparation to be 70 to 80%.
2.4. Reconstitution of P-gp into small proteoliposomes
We reconstituted P-gp into small proteoliposomes by the detergent-
dilution method as previously described [42–44]. Brieﬂy, we used 160–
250 μg of puriﬁed and concentrated P-gp.Wemixed the protein sample
with 4–5 mg of tip sonicated phospholipid mixture (same composition
as the solubilization reaction at 50 mg/mL in 50 mM Tris–HCl, pH 7.4),
1.25% octylglucoside, and 50 mM Tris–HCl, pH 7.4, in a ﬁnal volume of
1 ml [42,45]. We incubated the mixture for 20 min on ice and formed
proteoliposomes or control liposomes (prepared in the same way but
without protein) at 23–25 °C by a 1:25 dilution into buffer C com-
posed of 50 mM Tris–HCl, pH 7.4, 1 mM DTT, and 1× protease inhib-
itor cocktail (Roche Diagnostics, Indianapolis, IN). We concentrated
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washed once, and resuspended in 150 μL of buffer C containing
protease inhibitors and 2.5 mM MgCl2. The 1:25 dilution in buffer C
reduces the concentration of the detergent below its critical micelle
concentration (CMC) value, thereby breaking up the protein–detergent
micelles and facilitating the incorporation of P-gp into unilamellar ves-
icles in the inside-out conﬁguration [42–44].2.5. Formation of giant proteoliposomes
To form giant proteoliposomes from small proteoliposomes, we ex-
tended a technique that we described previously for the formation of
protein-free liposomes [24]. We prepared ~10 mL of a solution of 1%
(w/w) ultra-low melting agarose (Type IX-A from Sigma-Aldrich, St.
Louis, MO) in deionized water by boiling the suspension of agarose
powder and water twice in a microwave with gentle agitation between
heating. After the solution cooled to room temperature, we reheated it
for 10 s in a microwave and immediately dip-coated one side of a
cover glass (24 × 50 × 0.15 mm, from Fisher Scientiﬁc, Rochester, NY)
in the agarose solution. We placed the cover glass with the agarose-
coated side facing upward on a temperature-controlled hot plate
(Barnstead Intl, Dubuque, IA) and covered the glass with the lid from
a Petri dish set at an angle to allow water vapor to escape while
preventing dust from settling onto the agarose ﬁlm. The cover glass
remained on the hot plate with the temperature set to 40 °C until the
solution appeared dry (typically ~20 min).
After the agarose solution dried into a clear ﬁlm, we hand-cut a
rectangular frame of poly-dimethylsiloxane (PDMS) (Sylgard 184
Silicone, Dow Corning Corporation, Midland, MI) to the size of the
cover glass and placed the PDMS frame onto the agarose-coated side
of the cover glass. Using a pipette, we dispersed 150 μL of the solution
containing small proteoliposomes in small droplets (~10 μL each)
onto the dried ﬁlm of agarose while trying to cover the entire surface
enclosed within the PDMS frame. We dragged the pipette tip over the
tops of the droplets until they coalesced into a single ﬁlm of solution
while taking care not to disturb the underlying agarose ﬁlm.We placed
the lid from a Petri dish set at an angle over the cover glass and kept the
cover glass undisturbed overnight at room temperature, or until the
solution appeared dry. In the last few trials, we applied a vacuum
(approximately−500 mm Hg) to shorten the drying time to less than
2 h.
When the solution of small liposomes appeared dry, we added 1 mL
of 190 mM sucrose, 1 mM DTT, and 1× protease inhibitor cocktail in
50 mM Tris–HCl, pH 7.0, placed the lid of a Petri dish over the cover
glass, and left it undisturbed for 3 h to allow formation of giant proteo-
liposomes. After formation,we transferred the giant proteoliposomes to
a microcentrifuge tube (1.5 mL volume, Eppendorf, Westbury, NY)
while taking care not to transfer visible pieces of the agarose ﬁlm.2.6. Assessment of P-gp by ATPase activity after reconstitution into giant
liposomes
In order to determine the rate of ATP hydrolysis of reconstituted
liposomes, we incubated them with 30 μM verapamil (a substrate of
P-gp) in the presence and absence of 300 μM vanadate in ATPase
assay buffer for 10 min at 37 °C. This ATPase assay buffer contained
50 μM KCl, 5 mM NaN3, 2 mM EGTA, 10 mMMgCl2, 1 mM DTT, 2 mM
ouabain, and 50 mM Tris–HCl, pH 7.5. We used vanadate to inhibit the
ATPase activity of P-gp. We started the reaction by adding 5 mM ATP
and incubated for 20 min at 37 °C. We terminated the reaction with
the addition of SDS solution (0.1 mL of 5% w/v SDS) and quantiﬁed
the amount of inorganic phosphate released by a sensitive colorimetric
reaction as described previously [28]. We recorded the speciﬁc activity
of the transporter as vanadate-sensitive ATPase activity [28].2.7. Measurement of P-gp transport rate
Weprepared assay solutions at 2× the desired ﬁnal concentration of
magnesium ions, Rho123, and ATP to account for dilution of these mol-
ecules when mixed with an equal volume of solution containing giant
liposomes. We used a concentration of sorbitol that was isoosmolar to
the sucrose solution used to form giant proteoliposomes such that the
giant proteoliposomes would settle quickly due to the density differ-
ence (see Supporting Information, Fig. S1) with minimal or no swelling
or shrinking fromwater ﬂux across themembrane. Assay solutionwith-
out ATP consisted of 207mM sorbitol, 50 mMTris, pH 7.0, 8 mMMgCl2,
and 2 μMRho123. Assay solutionwith ATPwas the same supplemented
with 2 mM ATP. To inhibit the P-gp-mediated transport of Rho123
competitively, we transferred a portion of the solution containing
giant proteoliposomes to a separatemicrocentrifuge tube, added verap-
amil to a ﬁnal concentration of 30 μM, and incubated them at room tem-
perature for N15 min before use. Assay solution with inhibitor was the
same as assay solution with ATP supplemented with 30 μM verapamil.
Formicroscopic observation of transport,we punched5mmdiameter
holes in a slab of PDMS (approximately 2mmthick) and adhered the pre-
punched PDMS to a cover glass to formwells for viewing giant liposomes.
We incubated these wells with 5% milk (w/v nonfat dry milk powder in
phosphate buffered saline) to prevent non-speciﬁc adsorption that may
lead to rupture of giant liposomes on the surface of the glass. After rinsing
and drying thesewells, we placed 30 μL of assay solution into an observa-
tion well, added 30 μL of solution containing giant liposomes, and mixed
the contents of the well gently using the pipette. After waiting ~1 min to
allow the giant liposomes to settle to the bottom of the well, we focused
on a region that contained multiple liposomes and used a confocal
microscope (Nikon EZ-C1 software, version 3.20) to capture confocal
images at 1 min intervals for 30–60 min using an inverted micro-
scope (Nikon Eclipse TE2000-U) with a 20× objective (Nikon,
NA = 0.75) and equipped with an argon laser (Spectra-physics,
wavelength = 488 nm), a helium–neon laser (Melles-Griot, wave-
length= 543 nm), appropriate ﬁlter settings for Rho123, and a pinhole
diameter of 33.3 μm.
2.8. Data analysis
Weused EZ-C1 viewer (Nikon, version 3.50) tomeasure the diameter
of liposomes and the ﬂuorescence intensity of their interiors, their mem-
branes and the surrounding solution as a function of time. We deter-
mined that the ﬂuorescence intensity was linearly related to the
concentration of Rho123 in solution (see Supporting Information,
Fig. S2). To overcome any experimental variation, we performed a two
point calibration before each experiment to determine the Rho123 con-
centration from ﬂuorescence intensity values using the average intensity
inside GUVs without P-gp at the starting time (concentration of
Rho123 ~ 0 μM) and the average intensity of the solution outside of
GUVs at the starting time (concentration of Rho123 = 1 μM). For the
analysis of Ps and kT, we omitted liposomes that were clearly not
unilamellar or that visibly contained small vesicles inside (see Supporting
Information, Fig. S5), as well as liposomes whose ﬂuorescence increase
did not follow the model represented by Eq. (2) (i.e. R2 b 0.9). The
time-dependent ﬂuorescence increase (and hence the increase in
Rho123 concentration) of most liposomes could, however, be described
very well with Eq. (2) (R2 N 0.98).
We used a non-parametric Kruskal–Wallis test in Origin 8.0 to assess
the statistical signiﬁcance of the data for each experimental condition.
2.9. Patch clamp experiments with proteoliposomes
We placed a 20 μL drop of proteoliposome suspension in the center
of a 35 mm glass-bottom Petri dish (MatTek, Ashland, MA) that we had
pretreated with 5% milk (w/v dry nonfat milk powder in phosphate
buffered saline) for 30 min. Then we covered the dish with 2 mL of
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the center of the dish. Most of the giant proteopliposomes settled to the
bottom of the dish within a fewminutes. The bath solution consisted of
130 mM KCl, 1 mMMgCl2, and 10 mM HEPES with a pH titrated to 7.2
using KOH. The pipette solution was identical to the bath solution
supplemented with 5 mM ATP. We fabricated the patch electrodes
with resistances of 5.0–10.0 MΩ from borosilicate glass (Sutter Instru-
ments, Novato, CA) using a P-87 puller (Sutter Instruments, Novato,
CA). After formation of a Giga seal, we pulled the patch electrode
away from the giant proteoliposome and quickly went through the
water–air interface in order to ensure the inside-out conﬁguration.
We recorded the single channel current at room temperature using an
Axopatch 200B ampliﬁer (Molecular Devices, Sunnyvale, CA) and
digitized the recordings using a Digidata 1322A (Molecular Devices,
Sunnyvale, CA). The cut-off ﬁlter frequencywas 5 kHz and the sampling
rate was 25 kHz. Data acquisition was done using pClamp9 software
(Molecular Devices, Sunnyvale, CA).
3. Results and discussion
3.1. Hydrogel-assisted formation of giant proteoliposomes from small
proteoliposomes
We formed giant proteoliposomes that contained P-gp in the phos-
pholipid membrane in three steps by ﬁrst forming small proteolipo-
somes with P-gp, second, dehydrating the small proteoliposomes onto
a dried ﬁlm of ultra-low melting agarose, and third, rehydrating the
ﬁlm. Fusion of small proteoliposomes during the swelling of the partially
dried hydrogel [4,24,46] readily formed giant liposomes that contained
P-gp (Figs. 1A and S4C). Giant liposomes also formed readily from small
control liposomes that did not contain P-gp (Figs. 1B and S4A) using the
samemethod.Many of these giant liposomes had diameters larger than
10 μm. Since reconstitution of P-gp into small proteoliposomes has been
previously demonstrated to orient the protein in the inside-out orienta-
tion [34,42], we hypothesized that at least a fraction of P-gp would
reconstitute into giant proteoliposomes in the same inside-out orienta-
tion. This hypothesis stems fromwork by Girard et al. who demonstrat-
ed that ~70% of giant proteoliposomes maintained their proteinFig. 1. Confocal microscopy images of giant liposomes with or without reconstituted P-glyco
(Rho123) and 1 mM ATP. Row A) Giant proteoliposomes formed with P-gp. Row B) Control ex
but without P-gp in the membrane. Numbers in the upper left corner of each image indicat
giant proteoliposomes with an inhomogeneous interior that reveals the presence of small lipo
liposomeswith interiors that exhibited a change in ﬂuorescence intensity over time andwere in
port rates, kT. Scale bar = 100 μm.orientation after preparation by alternating electric ﬁeld-induced fusion
of partially dehydrated small proteoliposomes. In other words, fusion of
small liposomes with membrane proteins reconstituted in the inside-
out conﬁguration led to giant proteoliposomeswith amajority of mem-
brane proteins in the same inside-out orientation. Since the hydrogel
swelling reported here also induced fusion of previously-formed, par-
tially dehydrated small proteoliposomes with inside-out orientation,
we considered a similar bias towards more proteins in the inside-out
conﬁguration likely although we cannot rule out a random distribution
of orientations or an opposite bias towards a preferred outside-out ori-
entation. The results in Figs. 2 and 3, however, demonstrate that a sig-
niﬁcant fraction of P-gp proteins were oriented in the inside-out
conﬁguration since directional, active transport of Rho123 into the lipo-
somes occurred. In contrast, had all P-gpmolecules been oriented in the
outside-out orientation, this active transport would not have been sig-
niﬁcant compared to passive transport. This inward direction of active
transport means that the ATP-binding domain of P-gp was accessible
on the exterior of the proteoliposomes and that ATP hydrolysis enabled
directional transport of Rho123 into the liposomes as expected for the
inside-out orientation as opposed to efﬂux of substrate as naturally
occurs in cells when P-gp is oriented outside-out.
To test the functionality of the reconstituted P-gp, we measured the
ATPase activity on giant and small proteoliposomes that contain P-gp.We
found that stimulationwith thewell-known P-gp substrate verapamil re-
sulted in a higher level of ATPase activity compared to that observed in
the absence of verapamil (see Supporting Information, Table S1). This
substrate-induced ATP hydrolysis indicated that a signiﬁcant fraction of
P-gp was measurably active with the ATP-binding domain accessible to
the external solution after the process of reconstitution via dried ﬁlms
of ultra-low melting agarose [30,41,42].
3.2. Assessment of protein function using a transport assay
To test for active transport of substrates into giant proteoliposomes by
P-gp, we developed a transport assay using a P-gp substrate, rhodamine
123 (Rho123), which is a ﬂuorescent molecule that emits green light
[30,32,37,47,48]. The use of larger giant proteoliposomes (N10 μm) in
combination with confocal microscopy could be advantageous because,protein (P-gp) in a solution containing 1 μM of the ﬂuorescent substrate rhodamine 123
periment with giant liposomes that were formed in the same way as the P-gp liposomes
e elapsed time after immersion in Rho123 solution in minutes. The red arrows indicate
somes inside (see also Supporting Information Fig. S5D, E). White arrows indicate proteo-
cluded in the data analysis to obtain permeability coefﬁcients, Ps, and P-gp-induced trans-
Fig. 2. Time-dependent ﬂuorescence intensity inside giant liposomes (Iin,t) divided by theﬂuorescence intensity of the background (Iout,t). All giant liposomeswere assayed in the presence
of 1 μM of Rho123. In addition, giant proteoliposomes formed with P-gp were assayed (A) with 1 mM ATP, (B) without ATP, and (C) with 1 mM ATP and 30 μM verapamil and (D) giant
proteoliposomes formedwithout P-gp were assayedwith 1mMATP. In all graphs “0” time refers to the moment of addition of assay solution (i.e., the start of transport). The dashed gray
line shows the level at which the ﬂuorescence intensity inside giant liposomes equals the intensity of the external solution.
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the liposomes is located at a sufﬁcient distance from the liposome mem-
brane, thereby minimizing background signal from membrane-bound
ﬂuorescent substrate molecules [2]. These giant proteoliposomes are
also straightforward to distinguish individually such that they provide
liposome-speciﬁc transport data over time [2].Fig. 3.Determination ofmembrane permeability, Ps and rate of P-gp-induced active transport, kT o
liposomes (Cin,t) divided by its concentration in the external solution (Cout,t) and best curve ﬁts of E
of liposome, r=18 μm, Ps=8.8 × 10−9m s−1, kT=9.7m3mol−1 s−1, R2 of ﬁt= 0.997), ( ) wit
0.96), ( ) with P-gp, 1 mMATP and 30 μMverapamil (r=16 μm, Ps=4.7 × 10−9 m s−1, kT≈ 0
×10−10m s−1, kT=0m3mol−1 s−1,R2 ofﬁt=0.99), respectively. Curveﬁts are shownas solid cu
values for the membrane permeability, Ps (B) and rate of P-gp-induced active transport, kT (C) of R
each condition (from left to right, all in m s−1) were: 9.8 × 10−9, 9.6 × 10−9, 8.8 × 10−9,
in m3 mol−1 s−1) were: kT = 7.1, kT≈ 0, and kT≈ 0. The number of liposomes represente
the mean (open square), the median (horizontal line inside the box), the 25th and 75th p
and upper whisker), and the 1st and 99th percentiles (lower and upper asterisk).When collecting time-lapse series of ﬂuorescence images following
immersion of giant proteoliposomes in a solution containing 1 μM
Rho123, we observed a change in ﬂuorescence intensity inside giant
proteoliposomes containing P-gp but not in control GUVs that lacked
P-gp (Fig. 1). This difference indicated that P-gp was indeed present in
the membranes of giant liposomes following the reconstitution processf Rho123. A) Sample data showing the time-dependent concentration of Rho123 inside giant
q. (2) to the data under four different assay conditions: ( ) with P-gp and 1mMATP (radius
h P-gp butwithout ATP (r=15 μm, Ps=3.9 × 10−9m s−1, kT≈ 0m3mol−1 s−1, R2 of ﬁt=
m3mol−1 s−1, R2 of ﬁt = 0.99), and■) Giant liposomes without P-gp (r=15 μm, Ps=3.2
rves in the corresponding color. B, C) Boxplots of experimentally determineddistributions of
ho123 into giant liposomes under different test conditions. The median Ps values for
and 9.9 × 10−10. The median kT values for liposomes with P-gp (from left to right, all
d in the box plot for each condition is given by n. Symbols in the box plots represent
ercentiles (lower and upper bound of the box), the 5th and 95th percentiles (lower
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ﬂuorescence intensity of the interior started low, we surmised the
giant liposome was ﬁlled initially with the ﬂuid used to reconstitute
the liposome and, therefore, we attributed a time-dependent increase
in ﬂuorescence intensity to active transport and passive diffusion of
Rho123 from the external solution, across the membrane, and into the
internal solution.
During these experiments, we noted a frequent occurrence of bright
ﬂuorescent rings in confocal microscopy images of the membranes of
giant liposomes containing P-gp (as compared to the background or to
the ﬂuorescence of the liposome interior). In contrast, giant liposomes
that were generated without P-gp rarely showed these bright ﬂuores-
centmembranes (Fig. 1). These observations indicate that the difference
in membrane ﬂuorescence may be due to the presence of P-gp. Since
Rho123 is a substrate of P-gp, one possible explanation for the bright
ﬂuorescent membranes could be Rho123 binding to P-gp reconstituted
in thesemembranes. Another possible explanationmay bederived from
the known accumulation of Rho123 in the lipid membrane [37,47].
Therefore, we speculate that the difference in membrane ﬂuorescence
between giant liposomes that did not contain P-gp and proteoliposomes
containing P-gp may be due to the presence of P-gp and possible co-
reconstituted impurities or due to induced membrane defects from
either one of these reconstituted entities, which ultimately enhanced
the partitioning of Rho123 in the membrane of these proteoliposomes.
We observed bright ﬂuorescent rings with membranes that underwent
P-gp reconstitution in both the presence and absence of ATP or verapa-
mil (see Supporting Information, Fig. S4). These results indicate that
ATP was not required for Rho123 to associate with P-gp-containing
membranes and that the presence of verapamil, a known competitive
inhibitor of P-gp-mediated transport of Rho123 [30,32,42,49], was not
able to out-compete this association completely.
We also observed the occurrence of liposomes with reconstituted
P-gp that reached the ﬂuorescence outside the liposomes within the
ﬁrst few minutes after immersion in Rho123 solution and did not
change in ﬂuorescence intensity over time (Fig. 1 and Supporting Infor-
mation, Fig. S5). These liposomes were present in images of giant pro-
teoliposomes when active transport was enabled (e.g., with ATP) as
well as impeded (e.g., without ATP or in the presence of inhibitor) and
these liposomes even occurred occasionally, but much less frequently,
in preparations that did not contain reconstituted P-gp (see Supporting
Information, Fig. S5C). These liposomes were ﬁlled with Rho123 most
likely due to membrane leakiness or defects (e.g., due to the presence
of misfolded P-gp). We also observed brightly ﬂuorescing liposomes
with dark circular spots inside, indicating the presence of enclosed
regions that contained relatively low concentrations of Rho123 as com-
pared to their surroundings (indicated by red arrows in Figs. 1A, and
S5D, E). We attribute these spots to the inclusion of small vesicles [36,
50,51] whose interiors contained relatively low concentration of
Rho123 perhaps due to the extra barrier to permeation that their
membranes represent or due to their low membrane permeability.
Thepresence of these encapsulated vesicles offers a possible explanation
for the fraction of bright ﬂuorescing giant liposomes described above:
the close proximity of adjacent membranes may allow membrane-to-
membrane transfer (or short diffusion times between membranes) of
Rho123 and the subsequent additive membrane reservoir (each of
which ﬂuoresces more than background) hence increases the ﬂuores-
cence intensity inside these multivesicular giant liposomes [36,50,51].
Fig. S5D and E show examples of such liposomes, which were excluded
from the data analysis.
To quantify active transport resulting from P-gp, we measured the
ﬂuorescence intensity inside the liposomes with respect to the ﬂuores-
cence intensity outside liposomes (background ﬂuorescence) over time
under four different assay conditions: 1) with P-gp and 1 mM ATP,
2)with P-gp butwithout ATP, 3) with P-gp, 1mMATP and 30 μMverap-
amil to inhibit active transport of Rho123 by P-gp, and 4) without P-gp
(Fig. 2). The ﬂuorescence intensity inside giant proteoliposomes formedwith P-gp increased quickly in the ﬁrst 10–15 min after immersion in
1 μMRho123 assay solution (Fig. 2A), whereas the ﬂuorescence intensity
inside giant liposomes without P-gp typically remained low (Fig. 2D). As
expected for active transport of Rho123, the ﬂuorescence intensity inside
giant proteoliposomes exceeded the intensity of the background ﬂuores-
cencemore often in the presence of 1mMATP thanwithout ATP or in the
presence of an inhibitor (Fig. 2A). Although we observed the ﬂuores-
cence intensity inside a few giant proteoliposomes rising higher than
the background ﬂuorescence when assayed without ATP (Fig. 2B),
these intensities reached a plateau, whereas in the presence of ATP the
intensities in many of the proteoliposomes continued to rise (Fig. 2A).
Note that Fig. 2A–D shows the raw data without accounting for varia-
tions in liposome size. Therefore, individual curves cannot be directly
compared with regard to Ps and kT values of Rho123 inﬂux (see Eq. (2)).
3.3. Model of Rho123 ﬂux that includes passive diffusion and P-gp-mediated
active transport
The change in the concentration of Rho123 inside a liposome is due
to molecules of Rho123 crossing the membrane into the liposome.
Molecules can cross a membrane via passive diffusion in a manner
that depends on the difference in concentration on each side of the
membrane and a rate constant of diffusion also called the permeability
coefﬁcient, Ps (m s−1), or via active transport in the presence of active
transporter proteins that, in the case studied here, depends on the con-
centration of ATP and a rate constant of transport. In our analysis, we
combined the concentration of ATP (which we held constant) and the
rate of transport into one variable, kT (m3 mol−1 s−1). Since ATP was
added only to the external solution and its diffusion into liposomes
was assumed to negligible [52], active transport yielded a net ﬂux
from outside to inside the liposome, independent of the concentration
of Rho123 inside the liposome. We modeled the change in the concen-
tration of Rho123 in giant liposomes over time t (s) with Eq. (1), which
separates the passive transport term [2,53] from the active transport
term [54]. The passive transport term stems from Fick's Law and
accounts for diffusion across a biological membrane of a spherical lipo-
some with surface area A. The active transport term accounts for the
rate of transport as a function of surface density of P-gp and surface
area of liposomes. In this equation V is the liposome volume (m3),
Cin is the solute concentration of interest (mol m−3) inside the lipo-
somes, A is the surface area of the liposomes (m2), (Cout− Cin) is the dif-
ference in concentration of solute across the membrane (from external
solution to the interior), and ΓPgp is the surface density of P-gp in the
membrane (mol m−2).
V
dCin
dt
¼ Ps A Cout−Cinð Þ þ kT ΓPgp A Cout ð1Þ
By assuming a constant external concentration of Rho123 sur-
rounding the liposome as well as spherical liposomes with constant
volume, integrating Eq. (1) from 0 μM (Cin at t0) to Cin,t and from t0 to
t yields Eq. (2),
Cin
Cout
¼ 1−e−
3PS
r t−t0ð Þ
 
1þ kTΓPgp
PS
 
ð2Þ
where r is the measured liposome radius (m) and 3r−1 is the result of
the surface area of a sphere divided by its volume.
We estimated the surface density of P-gp in the membranes of lipo-
somes to be 7.6 × 10−11 molm2 , based on the ratio of startingmaterials (see
Supporting Information).We then accounted for possibleﬂuctuations of
theﬂuorescence detection bydetermining the ratio in concentration be-
tween external and internal solutions CinCout
 
at each time point. Best
curve ﬁts of Eq. (2) to this ratio as a function of time determined kT, Ps
and t0 for each liposome that contained P-gp. Fits to this data from
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case the surface density of P-gp was zero and no active transport
could occur, simplifying Eq. (2) to CinCout ¼ 1− e−3PS=r t−toð Þ. Fig. 3A shows
sample curves from each of the four assay conditions that show CinCout as
a function of time and the ﬁts of Eq. (2) to these ratios. Due to the
assumptions made to estimate the surface concentration of P-gp, the
kT values determined from curve ﬁts are limited to estimates of the
active transport rates of P-gp. Nonetheless, we applied various assay
conditions to the same batch of liposomes; therefore, these kT values
were useful for comparing the effect of different conditions on the trans-
port rate of P-gp (Fig. 3C). In fact, the median transport rate of P-gp in
the absence of ATP or in the presence of inhibitor is very close to zero,
indicating that no active transport occurs under these conditions
(Fig. 3C).
A non-parametric Kruskal–Wallis test used to compare distributions
of Ps and kT values in Fig. 3B and C revealed that all three conditions of
liposomes with reconstituted P-gp had a similar Ps value, whereas lipo-
somes without P-gp had a Ps value that was ~10-fold lower than the
liposomes that contained P-gp (p b 0.05) (Fig. 3B). These results indi-
cate that the presence of P-gp in the membrane increased the passive
membrane permeability of Rho123, even when active transport was
not enabled. The median Ps of Rho123 across GUV membranes without
P-gp (9.9 × 10−10 m s−1) is approximately one order of magnitude
smaller than a previously reported Ps value of Rho123 diffusion across
liposomemembranes [55] and approximately two orders of magnitude
smaller than the Ps value across basolateral membranes of MDCK cells
(1 × 10−7 m s−1) [56] as well as the reported Ps values of other
known P-gp substrates. For example, Ps values for vincristine,
vinblastin, and verapamil across the apical membrane of Caco-2 cells
were 3.3 × 10−9, 1.8 × 10−7, and 5.2 × 10−6 m s−1, respectively [57].
The low Ps value determined in control liposomes without P-gp suggests
that the presence of agarose and association of agarose with the lipo-
somes [24] did not render the liposome membranes leaky to “mem-
brane-impermeable” molecules such as Rho123, as can be seen in the
30 min panel of Fig. 1B. Formation of liposomes from a ﬁlm of ultra-low
melting agarose hence led to giant liposomes with comparable, low-
permeability-characteristics than liposomes prepared by other methods
[55,58].
With regard to the 10-fold increased Ps value in liposomes with
reconstituted proteins, some degree of increased leakiness is commonly
observed [39]. The results reported here, however, indicate a strong in-
crease in leakiness in liposomes that underwent reconstitution of P-gp
compared to control liposomes without P-gp. We could not differenti-
ate, whether this 10-fold increase in Ps value was due to high local con-
centration of Rho123 in the P-gp containing membranes, leakiness of
the membrane itself (e.g., due to packing defects between lipids in the
membrane induced by the nearby presence of P-gp), passage along
the surface of P-gp (e.g., via passive transport caused by random chang-
es of P-gp conformation from inward-facing to outward-facing and vice
versa) or a combination of these or other effects.We based the choice of
lipid for reconstitution on previously reported protocols that have been
used to successfully reconstitute functional P-gp into SUVs. One possible
reason could be that giant liposomes that underwent P-gp reconstitution
interactedmore stronglywith the glassmicroscope slides than giant lipo-
somes without P-gp. Such interactions of large proteoliposomes have
previously been observed to induce leaks. Despite this unfavorable large
leakiness of P-gp containing giant liposomes, the Kruskal–Wallis test
nonetheless revealed that the distribution of kT values for liposomes
with active transport (i.e., containing P-gp and assayed with ATP and
without verapamil) was signiﬁcantly higher than the kT values for lipo-
somes assayed without ATP (p b 0.05) or in the presence of verapamil
(p b 0.05) (Fig. 3C), indicating that active transport could still be differen-
tiated from passive transport or leaks.
Similar to the passive transport, the rate of accumulation of P-gp
substrate inside the liposome due to active transport is dependent on
the size of the liposome. The observed increase in the values of kT inthe presence of ATP and absence of inhibitor indicates active transport
by functional P-gp in the inside-out orientation (Fig. 3C). Additional
evidence for active transport stems from the observation that the ﬂuo-
rescence intensity inside the liposomes exceeded the intensity outside
the liposomes for several liposomes after assay durations of at least
20 min and continued to increase thereafter, whereas the ﬂuorescence
intensity inside liposomes without ATP or with inhibitor reached a
plateau at lower levels (Figs. 2 and 3A). These results indicate that func-
tionally active P-gp proteins were reconstituted from small proteolipo-
somes into giant proteoliposomes via a dried ﬁlm of ultra-low melting
agarose. Furthermore, ATP-mediated transport of Rho123 into giant
proteoliposomes demonstrated that a signiﬁcant fraction of the active
P-gp retained their inside-out orientation.
A signiﬁcant beneﬁt of using giant proteoliposomes for transport
analyses is the ability to discern and evaluate vesicles individually. As
shown in Eq. (1), the concentration (or number) of molecules trans-
ported into the liposome is dependent on the surface area of the vesicle.
Methods of generating giant proteoliposomes (as well as small proteo-
liposomes), however, yield a heterogeneous population with a wide
range of sizes. Here we report that a liposome-based transport assay
that is simple to perform, yields concentration data of ﬂuorescent sub-
strates with respect to vesicle size, and provides the ability to visually
assess individual liposomes for irregularities and artifacts that could
affect the inﬂux of substrates. For example, as discussed previously,
bright spots inside a fraction of liposomes likely corresponded to
multilamellar liposomes or to giant liposomes ﬁlled with small vesicles.
The presence of such internalized liposomes is not unusual for methods
of generating giant liposomes with embedded membrane proteins
based on variations of the gentle hydration method [51], but could
skew the results when liposomes are too small to discern individually
due to the brightness of the membrane ﬂuorescence. The giant proteo-
liposomes preparedwith themethod presented heremake it possible to
exclude such artifacts from the analysis.
3.4. Evaluation of ion channel activity of chloride channels co-puriﬁed with
P-gp
Previous reports have associated P-gpwith chloride channel activity,
presumably by co-puriﬁcation of these channels with P-gp [33,34,
59–62]. Therefore, as an additional means of testing the functionality
of proteins reconstituted in giant proteoliposomes via themethod intro-
duced here, we performed patch clamp experiments employing the
inside-out conﬁguration from giant proteoliposomes and compared
the current recorded from membranes of GUVs containing P-gp with
the current recorded from membranes without P-gp (Fig. 4). These
giant proteoliposomes with large diameters (N10 μm) are well suited
for performing these experiments.
We observed transient and distinct open and closed states in the
patch clamp recordings of membrane patches from giant proteolipo-
somes that contained P-gp (Fig. 4B). In comparison, patch clamp record-
ings of membrane patches from GUVs that lacked P-gp but were
otherwise formed with the same protocol from a ﬁlm of agarose did
not show current ﬂuctuations beyond baseline noise (Fig. 4A). These re-
sults indicate that functional ion channel proteins were reconstituted in
giant proteoliposomeswhen reconstituting the puriﬁed P-gp preparation
by the method reported here.
To investigate if these ion channel activities originated from chloride
channel proteins that co-puriﬁed with P-gp from the host insect cells, we
applied two well-known chloride channel inhibitors (Fig. S6) and found
that channel activity was blocked in the presence of 100 μMof the potent
chloride channel inhibitor, 5-nitro-2-(3-phenylpropylamino)benzoic acid
(NPPB), but was restored after washing out the inhibitor as expected [63,
64]. Channel activity was irreversibly blocked after application of 50 μM
Gd3+, as expected for chloride channels [63,65]. The results indicate the
presence of chloride channel proteins in giant proteoliposomes contain-
ing puriﬁed P-gp and agreewith previous studies [64,66,67]. For instance,
Fig. 4. Patch clamp recordings from giant liposomes formed on an agarose ﬁlm from small
liposomes that contained or did not contain puriﬁed P-glycoprotein (P-gp). Single channel
currents were recorded after excising amembrane patch from the proteoliposomes in the
inside-out conﬁguration at a holding potential of−100 mV. (A) Current trace of single
channel recordings from a control GUV without P-gp. (B) Current traces of single channel
recordings from giant proteoliposomeswith reconstituted puriﬁed P-gp. Traceswereﬁltered
at 2 kHz. The mean single channel conductance values were (from top to bottom panel): 6,
19, 37, and 245 pS, respectively.
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25.2 pS from multi-drug resistance cell lines while Duan et al. [67] re-
ported a single channel conductance value of 40 pS. In addition,
Schwiebert et al. [66] observed a large conductance chloride channelFig. 5. Confocal and phase contrast images of giant liposomes formed from small proteoliposom
before reconstitution in an aqueous solution of 10 mM Tris (pH 7.0), 190 mM sucrose, 1 mM d
added to assay solution containing Rho123 and ATP to ﬁnal concentrations of 1 μM and 1 mM
here. B) Phase contrast image of giant proteoliposomes formed using the method reported her
somes formed by following the method reported by Riquelme et al. [17]. Small proteoliposom
Dehydration of small proteoliposomes was followed by overnight reconstitution in the aqueouwith a single channel conductance value of 305 pS. Together, these con-
ductance values compare well with the ones obtained from Fig. 4.
3.5. Comparison with a previously described reconstitution method
When choosing a method for reconstituting proteins into giant
proteoliposomes, the required properties of the resulting liposomes
must be considered. For example, to study ion channels using the tradi-
tional, pipette-based patch clamp technique, only a few giant proteoli-
posomes need to be present because the experimentalist can select a
proteoliposome of choice from a heterogeneous population. In addition,
the presence of lipid vesicles inside such giant liposomes is of no con-
cern since only the outer liposome membrane is accessed and excised
by the patch pipette. For semi-automated, suction-based planar patch
clamp assays [68–70], however, a high concentration of unilamellar
proteoliposomes with large diameters is desirable to ensure acceptable
success rates of bilayer formation overmicro- or nanopores [6]. Similarly,
the ideal case for ﬂuorescence-based transport assays as described in the
work presented here would be an abundance of unilamellar proteolipo-
somes with diameters larger than 10 μm so that inﬂux of solutes into
liposomes can be readily monitored and analyzed using time series of
images. Ideally most of these liposomes would not contain other lipo-
someswithin them, since the volume excluded by such internalized lipo-
somes may reduce the effective volume of the GUV. To compare the
agarose-based method presented here with an existing method for
producing giant proteoliposomes,we formed giant liposomes containing
P-gp using the gentle hydration method presented by Riquelme et al.
[17]. Both methods could produce a similar yield of giant liposomes
after collecting free-ﬂoating liposomes using a pipette. Formation of
giant proteoliposomes using the previously described method of gentle
hydration was, however, less reliable (some trials yielded very few
free-ﬂoating giant proteoliposomes) than the formation from a ﬁlm of
ultra-low melting agarose described here (every trial produced a good
yield of giant proteoliposomes). We also found that the previously de-
scribed method [17] produced liposomes that were more often packed
with small liposomes compared to the method presented here (Fig. 5).
While these internal liposomes did not interfere with the patch clamp
studies performed by Riquelme et al. [17], these types of liposomes
were not suitable for transport assays that measure the ﬂuorescence
intensity inside liposomes as described here. Therefore, the yield of suit-
able proteoliposomes for ﬂuorescent ﬂux assays was signiﬁcantly higher
when formation was facilitated by a ﬁlm of ultra-lowmelting agarose in
comparison to the previously established protocol.
3.6. Evaluation of the lamellarity of the resulting proteoliposomes
We followed aﬂuorescence-based procedure reported byAkashi et al.
to evaluate whether the proteoliposomes prepared by the methodes. Small proteoliposomes were dehydrated on a dried ﬁlm of ultra-lowmelting agarose
ithiothreitol, and 1× protease inhibitor. After reconstitution, giant proteoliposomes were
respectively. A) Confocal image of a giant proteoliposome formed by the method reported
e (same as in A, but without assay solution). C) Phase contrast image of giant proteolipo-
es were partially dehydrated on bare glass in the presence of 5% (v/v) ethylene glycol.
s solution used in (A and B). Scale bars = 50 μm.
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the Rho123-induced membrane ﬂuorescence as a function of
proteoliposome diameter as well as the resulting distribution of mem-
brane ﬂuorescence values. The presence of one major peak in the distri-
bution of membrane ﬂuorescence suggests that the majority of
proteoliposomes that were used for quantitative ﬂux analysis as deﬁned
by the criteria in the Materials and methods section and the main text
were unilamellar.We note, however, that these criteria excluded a signif-
icant fraction of liposomes that were ﬁlled with bright ﬂuorescence and
were therefore obviously multilamellar or multivesicular. As exempliﬁed
for instance in the 30min panel of Fig. 1A, only the proteoliposomes indi-
cated by white arrows passed the criteria for quantitative analysis in this
particular ﬂuorescent micrograph. Fig. 6 shows that within the fraction
that passed the criteria for quantitative analysis, only six of 76 liposomes
had magnitudes of membrane ﬂuorescence signiﬁcantly above the ﬁrst
peak in the distribution and were hence considered multilamellar.
4. Conclusion
Dried ﬁlms of ultra-low melting agarose facilitated the formation of
giant proteoliposomes from small proteoliposomes. The resulting giant
proteoliposomes contained puriﬁed P-gp transporters and exhibited
(i) increased ATPase activity following stimulation with a known trans-
port substrate compared to pre-stimulation activity, (ii) elevated mem-
brane permeabilities to Rho123 in liposomes containing P-gp compared
to liposomes lacking P-gp, (iii) elevated rates of transport under condi-
tions conducive to active transport by P-gp compared to conditions
without ATP or with an inhibitor, and (iv) single ion channel currents
consistent with co-puriﬁed chloride channel proteins. Together, these
results demonstrate that this technique yielded functional reconstitu-
tion of puriﬁed transmembrane proteins such as P-gp and chloride ion
channels into giant proteoliposomes. At least a fraction of the P-gp pro-
teins remained in the inside-out orientation, wherein the ATP-binding
and substrate-binding domains were exposed to the external solution.
Unlike cellular assays, this orientation allows straightforward and
rapid alteration of the environment surrounding these domains and
provides a means of studying direct effects of potential inhibitors and
ATP concentration on the rate of transport. Agarose-mediated reconstitu-
tion of transmembrane proteins into giant liposomes resulted in a good
yield of giant proteoliposomes, which contained a signiﬁcant fraction of
liposomes that were free of internalized vesicles and hence suitable for
transport studies and may enable experiments with semi-automated
planar patch clamp experiments on reconstituted and puriﬁed proteins.Fig. 6. Adjustedmembrane ﬂuorescence from Rho123 as a function of proteoliposome di-
ameter and corresponding distribution of membrane ﬂuorescence values. In this analysis
the peak with the lowest membrane ﬂuorescence value (here 1245 AU) is attributed to
unilamellar liposomes, while liposomes with signiﬁcantly higher membrane ﬂuorescence
are considered multilamellar [24,50]. Adjusted membrane ﬂuorescence is deﬁned as (in-
tensity of membrane ﬂuorescence) / (intensity of local background ﬂuorescence/average
of the intensity of the background ﬂuorescence from all analyzed images).The major disadvantage of the method presented here was the
unexpectedly large ﬂux of Rho123 through the resulting liposomes by
passive diffusion in the proteoliposomes with reconstituted P-gp.
Since we used a previously published lipid mixture for P-gp reconstitu-
tion, we do not know the reason for the 10-fold increased leakiness of
membranes containing P-gp compared to the control liposomes with-
out P-gp. It remains to be seen if similar problems of leakiness will ap-
pear with reconstituted proteins other than P-gp or if this problem
was protein-speciﬁc. Recently Lira et al. reported that liposomes,
which were also formed from ﬁlms of agarose and were initially tight,
became permeable to solutes upon transient pore formation by electro-
poration [58]. The authors explained this effect by trapping of agarose
molecules in the membrane pores and a resulting attenuation of spon-
taneous pore closure. As one possible explanation for the increased
leakiness upon P-gp reconstitution, we speculate that the presence of
P-gp in the membranes may increase the probability of spontaneous
pore formation in the liposome membranes whose closure may be im-
peded by the same agarose-induced mechanism. If this is indeed the
case then one variation of our original hydrogel swelling method,
namely to use a chemically cross-linked hydrogel (as reported in the
Supporting Information of that paper [24]) whose monomers should
not be able to dissolve from the hydrogel would be expected to mini-
mize this problem. Moreover, Weinberger et al. [4] and Mora et al.
[46] have recently published the formation of giant liposomes from
other hydrogels whose monomers are not expected to dissolve from
the ﬁlm. Despite the current shortcomings of the approach presented
here, we nonetheless demonstrate that this reconstitution protocol
could be used for ion channel recordings with good quality and that a
model which considers both passive and active transport by one of
the most important multidrug resistance efﬂux pumps could distin-
guish between and quantify these two parameters.
Based on the results presented here, we propose that the giant pro-
teoliposomes formed by this reconstitution techniquemay provide a use-
ful model system for studying the direct effects of potential inhibitors on
the rate of active transport by P-gp and potentially other transport or ion
channel proteins under well-deﬁned conditions. We expect these sys-
tems to aid in drug development and in studying potential interactions
of transport proteins with lipids or ion channel proteins.
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Appendix A. Supplementary data
Calibration curves of osmolarity and density for solutions of sucrose
and sorbitol, calibration curve of concentration to ﬂuorescence intensi-
ty, puriﬁcation of P-gp, ATPase assay, ﬂuorescence of GUVs containing
P-gp, estimate of the number of proteins per liposome, and inhibition
of chloride channel reconstituted in GUVs with P-gp. Supplementary
data associated with this article can be found, in the online version, at
http://dx.doi.org/10.1016/j.bbamem.2014.10.023.
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